Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 15/20 | 0.36 |
| ▸ | CA1 | P00915 | 14/20 | 0.36 |
| ▸ | MMP1 | P03956 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 2/20 | 0.36 |
| ▸ | MMP9 | P14780 | 2/20 | 0.36 |
| ▸ | MMP8 | P22894 | 2/20 | 0.36 |
| ▸ | MMP13 | P45452 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2198314 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL6875127 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL6907023 | 1.00 | THRB (0.62) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL1766828 | 0.97 | THRB (0.57) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL865497 | 0.88 | THRB (0.46) | THRB | |
| SCHEMBL11584806 | 0.83 | THRB (0.44) | THRB | |
| SCHEMBL20478151 | 0.79 | THRB (0.65) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL20478148 | 0.79 | THRB (0.65) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL28417455 | 0.79 | THRB (0.65) | THRBLMNACA2CA1MMP1 | |
| SCHEMBL28030131 | 0.79 | THRB (0.65) | THRBLMNACA2CA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977429-B2 | Polymers and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20070154431-A1 | Novel polymers and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2007-07-05 | — | — | US | disclosed |
| EP-1719794-A1 | NOVEL POLYMERS AND USES THEREOF | Mitsui Takeda Chemicals, Inc. (JP) | 2006-11-08 | — | — | EP | disclosed |
| US-20040067311-A1 | Fluorinated-photoinitiators in dual cure resins | CIBA SPECIALTY CHEMICALS CORP. | 2004-04-08 | — | — | US | disclosed |
| EP-1392779-A1 | FLUORINATED-PHOTOINITIATORS IN DUAL CURE RESINS | Ciba SC Holding AG (CH) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002040602-A1 | FLUORINATED-PHOTOINITIATORS IN DUAL CURE RESINS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070154431-A1 | Novel polymers and uses thereof | RAD54L, VCL, TYR | THRB 3356/4885LMNA 2949/4885CA2 3672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.